Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Safety profile of thrombolytic drugs. — Aldo Maggioni (1995) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Safety profile of thrombolytic drugs.
Shared by
Aldo Maggioni
Safety profile of thrombolytic drugs.
Article
1995
pt
Authors
Aldo Maggioni
CF
Claudio Fresco
Related publications
Article
2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysis
Mario Cazzola
,
Luigino Calzetta
,
Peter J Barnes
,
Gerard J. Criner
,
Fernando J. Martínez
,
Alberto Papi
,
Maria Gabriella Matera
Article
2018
Efficacy and safety profile of xanthines in COPD: a network meta-analysis
Mario Cazzola
,
Luigino Calzetta
,
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Peter J Barnes
,
Gerard J. Criner
,
Fernando J. Martínez
,
Alberto Papi
,
Maria Gabriella Matera
Letter
1992
The Risk of Stroke after Thrombolytic Therapy
R Collins
,
Peter Sleight
,
Aldo Maggioni
Article
1983
Thrombolytic Therapy for Thromboembolism of Vertebrobasilar Artery
Giuseppe G. Nenci
,
Paolo Gresele
,
M Taramelli
,
Giancarlo Agnelli
,
E Signorini
Letter
2009
SCOUT Trial Reports on the Safety Profile of Sibutramine in Patients with Cardiovascular Diseases
Aldo Maggioni
Discussion(0)
No comments yet. Be the first to comment.